Re:Unconventional Case Study of Neoadjuvant Oncolytic Viroth...
by XorNot on Monday September 09, 2024 @03:42AM
(#41486294)
You're not adding money to the mix.
If a company or research group wants to sponsor an experimental treatment with patient approval and waiver free of charge, that's one thing.
But they almost immediately turn around and say " oh we'll need to cover costs..." and suddenly the incentive is very different.
Detect and punish scammers if they are an issue. Allow people to take risky medical treatments if they have serious incurable illnesses.